A three-snoRNA signature: SNORD15A, SNORD35B and SNORD60 as novel biomarker for renal cell carcinoma

Table 2 Correlation between snoRNA expression in TCGA and clinicopathologic characteristics of RCC patients

Characteristics		Cases	SNORD15A	SNORD35B	SNORD60
Characteristics		Cases	P Value	P Value	P Value
Gender	Male	335	0.0109*	0.0701	0.0602
Gender	Female	181	0.0109*	0.0701	0.0602
Age	>=50	416	0.0443*	0.0253*	0.4483
Age	< 50	100	0.0443*	0.0253*	0.4483
T stage	T1	259	0.0023*	0.0001*	0.1796
	T2	67
	T3	179
	T4	11
Lymph node metastasis	N0	228	0.9936	0.6330	0.9258
	N1	17
	Not Available	271
Distant metastasis	M0	406	0.3016	0.0062*	0.1947
	M1	78
	Not Available	32
TNM stage	I	253	0.0104*	0.0001*	0.1267
	II	55
	III	123
	IV	82
	Not Available	3
Grade	G1	13	0.0001*	0.0001*	0.0213*
	G2	218
	G3	202
	G4	75
	Not Available	8

ISSN: 1475-2867